These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18710613)

  • 1. [Effects of mitoxantrone on the activity of human protein kinase CK2 holoenzyme].
    Li CM; Liu XG; Lin XC; Chen XW; Liang NC
    Ai Zheng; 2008 Aug; 27(8):809-15. PubMed ID: 18710613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect and its kinetic analysis of baicalein on recombinant human protein kinase CK2 holoenzyme].
    Lin XC; Liu XG; Chen XW; Chen WZ; Liang NC
    Ai Zheng; 2004 Aug; 23(8):874-8. PubMed ID: 15301706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
    Liu XG; Liang NC
    Acta Pharmacol Sin; 2002 Jun; 23(6):556-61. PubMed ID: 12060532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of AG1109 on recombinant human protein kinase CK2 holoenzyme].
    Liu XG; Liang NC
    Ai Zheng; 2002 Feb; 21(2):153-7. PubMed ID: 12479065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect and kinetic analysis of sodium quercetin-7,4'-disulphate on recombinant human protein kinase CK2 holoenzyme].
    Liu XG; Liang NC; Liu W; She J; Mo LE
    Yao Xue Xue Bao; 2002 Mar; 37(3):165-8. PubMed ID: 12579753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase CK2 subunits are positive regulators of AKT kinase.
    Guerra B
    Int J Oncol; 2006 Mar; 28(3):685-93. PubMed ID: 16465374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and proapoptotic properties of new casein kinase II inhibitors.
    Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z
    Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-escin, a natural triterpenoid saponin from Chinese horse chestnut seeds, depresses HL-60 human leukaemia cell proliferation and induces apoptosis.
    Niu YP; Wu LM; Jiang YL; Wang WX; Li LD
    J Pharm Pharmacol; 2008 Sep; 60(9):1213-20. PubMed ID: 18718126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
    Schneider CC; Hessenauer A; Montenarh M; Götz C
    Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism].
    Wang Y; Zhu XF; Xiao ZJ; Wang HH; Zhou JM; Mei YP; Deng R; Jiang WQ; Liu ZC
    Ai Zheng; 2005 Dec; 24(12):1464-8. PubMed ID: 16351793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of protein kinase CK2 as oncological target.
    Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
    Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein Kinase II: an attractive target for anti-cancer drug design.
    Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
    Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
    Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
    Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
    FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine.
    Yamane K; Kinsella TJ
    Clin Cancer Res; 2005 Mar; 11(6):2355-63. PubMed ID: 15788687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induced by DNA primase inhibitor 3,3'-diethyl-9-methylthia-carbocyanine iodide in human leukemia HL-60 cells.
    Li ZM; Jiang WQ; Guan ZZ; Zhu XF; Zhou JM; Xie BF; Feng GK; Zhu ZY; Liu ZC
    Yao Xue Xue Bao; 2006 Oct; 41(10):978-84. PubMed ID: 17184117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.